Agreed we are all gun-shy with our history. But this news really will be not only more concrete than many of our previous tidbits, but it could add significantly to the NGIO value/IPO.

If this is successful, it could help give new investors something they can sink their teeth into: Scientific proof that it works (bolstered by an added test w FDA involvement), and a very high safety profile going into an IND and clinical testing.

And with our low float, how many new investors would it take to cause a rise in our price, if that is accompanied by a lack of desire to sell from our LT holders?

It will certainly be interesting. I'm still hoping for an announcement tomorrow or Friday morning...